EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL

Chen Chen, Zijuan Hu iD, Min Ren iD, Longlong Bao, Ran Wei, Tian Tian, Xiaoli Zhu, Qianming Bai, Baohua Yu, Xiaoqiu Li, Xiaoyan Zhou

Current Oncology · 2025

DOI: 10.3390/curroncol32090488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Chen Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Tumor Suppressor Protein p53. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation Group Project of Shanghai Municipal Health Commission, Shanghai Science and technology development fund, Shanghai Municipal Key Clinical Specialty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TP53 genetic alterations represent a critical molecular feature in diffuse large B-cell lymphoma (DLBCL), with well-established associations with aggressive disease behavior and therapeutic resistance. However, significant controversy persists regarding the clinical utility of p53 immunohistochemical (IHC) expression as a surrogate marker. This study presents a thorough investigation of TP53 genetic alterations and their correlation with p53 protein expression in 664 cases of DLBCL. Using targeted next-generation sequencing (tNGS), we identified TP53 alterations (mutations and/or copy number losses (CNLs)) in 170 cases (25.6%). Among them, 161 cases had mutations. Concurrent analysis of copy number variations (CNVs) in 109 cases revealed TP53 CNLs in 17.4% (19/109), with 68.4% (13/19) of these showing coexisting mutations. Immunohistochemical evaluation of p53 expression in 371 cases demonstrated strong positivity (≥65% cells) in 21% (78/371), complete negativity (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseTumor Suppressor Protein p53HumansImmunohistochemistryFemaleMalePrognosisMiddle AgedMutationAdultAgedDNA Copy Number VariationsAged, 80 and over

Stichwörter der Autor:innen

TP53 mutationscopy number variationdiffuse large B-cell lymphomanext-generation sequencingp53 immunohistochemistryprognostic markers

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

ORCID-Profile: Zijuan Hu, Min Ren

Förderung

  • Innovation Group Project of Shanghai Municipal Health Commission
  • Shanghai Science and technology development fund
  • Shanghai Municipal Key Clinical Specialty
  • Innovation Program of Shanghai Science and Technology Committee

Zitieren

APA

Chen, C., Hu, Z., Ren, M., Bao, L., Wei, R., Tian, T., Zhu, X., Bai, Q., Yu, B., Li, X., & Zhou, X. (2025). Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL. Current Oncology. https://doi.org/10.3390/curroncol32090488

Vancouver

Chen C, Hu Z, Ren M, Bao L, Wei R, Tian T, et al. Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL. Current Oncology. 2025. doi:10.3390/curroncol32090488

BibTeX
@article{Chen2025,
  author = {Chen, Chen and Hu, Zijuan and Ren, Min and Bao, Longlong and Wei, Ran and Tian, Tian and Zhu, Xiaoli and Bai, Qianming and Yu, Baohua and Li, Xiaoqiu and Zhou, Xiaoyan},
  title = {Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32090488}
}
Kostenlos starten →